National Storage Mechanism | Additional information
RNS Number : 4283B
Roebuck Food Group PLC
30 September 2025
 

 

Roebuck Food Group plc

Interim results 2025

Results

 

Roebuck Food Group plc (AIM: RFG) is pleased to announce its interim results for the six months to end June 2025.

 

The period reflects the acquisition of a 37.3% controlling shareholding in Glasport Bio Limited ("GPB") and a 16% investment in Glasport RumenTech Limited("GPRT") which were both completed on February 7th 2025. GPB  has made a lot of progress in the first six months towards commercialisation of GasAbate, its industry-leading manure treatment system for reducing emission of methane and other noxious gases. GPB is now in contract discussions on pilot installations with two potentially significant customers and in exploratory discussions with several others. The company is also progressing discussions regarding carbon-reduction certification.

 

GPRT which sits as an investment on our Balance Sheet, continues development work on its RumenGlas feed additive. Trials conducted with Teagasc (Ireland's agriculture and food development authority) have shown promising efficacy in reducing enteric methane, while at the same time improving livestock performance. GPRT is currently preparing to commence the regulatory filing and efficacy/safety trials process with the European Food Safety Authority (EFSA), with a view to having the product market-ready in 2028.

 

The consolidation of GPB in our interim results adds a layer of complexity to the reporting of our half-year numbers, with 100% of GPB's start-up losses taken through the income statement, with the non-owned 62.7% interest backed-out after the reported loss for the period.

 

The total loss generated by Roebuck Food Group Plc in the period amounted to £1.06m. This compares with a loss of £4.1m in the same period of the prior year. Within this overall loss of £1.06m, Glasport Bio generated a loss of £467,000 (of which £174,000 is attributable to Roebuck Food Group plc).

 

Elsewhere, Moorhead & McGavin, our plant-based ingredients business experienced a challenging trading period in what was a very difficult UK food-service market, with sales down 23%, reflecting in part the elimination of some less profitable business. Contribution was down by £335,000. Gross margins declined by 1%, year on year, reflecting some price deflation while costs increased, reflecting an investment in people.

 

Foro Food Solutions generated a loss of £54,000 for the period. This comprises a profit of £7,000 from our Sourcing business based in Cork, while our new Retail business (which commenced in September 2024) generated a start-up loss of £61,000. Head office costs at Roebuck Food Group reduced substantially, from £564,000 to £395,000.

 

 


 

Outlook

 

 

Regarding our plant-based ingredients and products business, we have seen a welcome improvement in trading trends in recent weeks and face less challenging like-for-like comparisons in the second half of the year.

 

Management are excited at the prospects for Roebuck Food Group plc. We have pivoted to a deep science business through the Glasport Bio and Glasport RumenTech transactions. All the information and progress to hand since completing these transactions confirms our believe that the science-underpinning these companies is robust, and the commercial opportunities are very significant.

 

We would like to compliment the GlasPort Bio and Glasport RumenTech teams on their continued success in attracting significant non-dilutive grant funding for multi-year collaborative research and demonstration projects with industry partners for their respective technologies, GasAbate and RumenGlas. Grants totalling €4.4m have been awarded by the Disruptive Technologies Innovation Fund (DTIF, €2.9m) and the Sustainable Energy Authority of Ireland (SEAI, €1.5m).

 

The DTIF matched-funding FutureLives project is in collaboration with Agri IoT and University of Galway, with a goal to enhance nutrient efficiency and significantly reduce greenhouse gas emissions, contributing to a more climate-resilient agricultural sector. The SEAI GasAbate Select project is in conjunction with Ashleigh Farms and will demonstrate how GasAbate treatment can transform animal manures into efficient, cost-effective feedstocks for green-energy production by medium-scale AD plants. The grant awards, which may be worth up to €2.4m in aggregate between GlasPort Bio and Glasport RumenTech, represent a further vote of confidence in these technologies regarding their potential for recycling nutrients and energy from livestock farming and decarbonisation of food production.

 

Dividend

The board does not recommend the payment of a dividend.

 

 


 

Roebuck Food Group Plc

 



 

 

 

 

 

Consolidated income statement

 




 

For the six months ended 30 June 2025

 




 


 




 


 

Six months

Six months



 

ended

ended



 

30 June

30 June



 

2025

2024



 

(Unaudited)

(Restated)



 

 




 

£'000

£'000


 

 

 



Continuing operations

 

 



Revenue

 

5,369

5,966


Cost of sales

 

(4,461)

(4,990)


Gross profit

 

908

976



 

 



Administrative expenses

 

(1,656)

(1,232)


Impairment of Intangible assets

 

(271)

(30)


Acquisition and related costs

 

(94)

(35)


 

Operating loss

 

(1,113)

(321)


 

 

 



Finance income - interest receivable

 

3

3


Finance expenses - interest on bank loans

 

(5)

(7)


Loss before taxation

 

(1,115)

(325)



 

 



Income taxes - Corporation tax

 

-

-


Income taxes - Deferred tax

 

-

-


Loss for the period from continuing operations

 

(1,115)

(325)



 

 



Loss from discontinued operations

 

(3)

(3,753)



 

 



Loss for the period

 

(1,118)

(4,078)



 

 



Other comprehensive losses

 

(1)

(11)



 

 

 


Total comprehensive loss for the period

 

(1,119)

(4,089)


Losses attributable to:

 

 



 

Owners of the parent


(826)


(4,089)

 

Non-Controlling Interest


(293)


-

 



(1,119)


(4,089)

 

From continuing operations

- basic

 

(0.88)p

     (0.65)p


 

- diluted

 

(0.88)p

(0.65)p


 

From discontinued operations

- basic

 

-

(7.5)p


 

- diluted

 

-

(7.5)p


 

 

 

 

 

 



 


 

 



 

 

Roebuck Food Group plc

 



 

Financial position

 



 

As at 30 June 2025

 



 

 

As at

As at

As at

 


30 June

30 June

31 December

 


2025

2024

2024

 


(Unaudited)

(Unaudited)

(Audited)

 


 



 


£'000

£'000

£'000

 

ASSETS

 



 

Non-current assets

 



 

Goodwill

1,959

-

-

 

Investments

833

-

-

 

Intangible assets

7,510

570

540

 

Property, plant and equipment

1,191

1,091

1,055

 


11,493

1,661

1,595

 

Current assets

 

 


 

Trade and other receivables

1,847

1,645

1,522

 

Inventories

1,377

1,061

1,302

 

Assets held for sale

-

4,274

-

 

Cash and cash equivalents

2,848

51

115

 


6,072

7,031

2,939

 

 

 

 


 

TOTAL ASSETS

17,565

8,692

4,534

 

 

 

 


 

Equity attributable to equity holders of the parent

And non-controlling interest

 

 


 

Share capital

2,077

990

990

 

Share premium account

8,938

2,094

2,094

 

Non-controlling interest

6,815

-

-

 

Other reserves

(99)

(105)

(98)

 

Retained earnings

(2,866)

(725)

(2,041)

 

TOTAL EQUITY

14,865

2,254

945

 

 

Non-current liabilities

 

 


 

Borrowings

17

28

9

 

Deferred tax

74

72

71

 

 

91

100

80

 

 

 

 

 

 

Current liabilities

 

 


 

Trade and other payables

2,322

1,770

2,919

 

Liabilities held for sale

-

4,405

-

 

Borrowings

287

163

590

 


2,609

6,338

3,509

 


 

 


 

TOTAL EQUITY AND LIABILITIES

17,565

8,692

4,534

 





 

 

 

 




 

 

Roebuck Food Group plc

 

Consolidated statement of changes in equity

For the six months ended 30 June 2025

 

 

 

 


 

 

Non

 

 

 

 

 

 

Share

Share

Other

Controlling

Retained

 

 

 

 

 

capital

premium

Reserves

Interest

earnings

Total

 

 

 


£'000

£'000

£'000

£'000

£'000

£'000

 

 

 










 

At 1 January 2024

990

2,094

(94)

-

3,353

6,343

 

 

 










 

Profit for the financial year

-

-

-

                          -

(4,078)

(4,078)



 

Foreign exchange gain

-

-

(11)

-

-

(11)



 

Total comprehensive income for the period

-

-

(11)

-

(4,078)

(4,089)

 

 

 

Issue of share capital

-

-

-

-

-

-



 

Equity dividends paid (recognised directly in equity)

-

-

-

-

-

-



 

Transactions with owners

-

-

(11)

-

(4,078)

(4,089)

 

 

 

At 30 June 2024

990

2,094

(105)

-

(725)

2,254

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the financial period

-

-

-

-

(1,316)

(1,316)



 

Foreign exchange loss

-

-

7

-

-

7



 

Total comprehensive income for the period

-

-

7

-

(1,316)

(1,309)

 

 

 

Issue of share capital

-

-

-

-

-

-



 

Share issue costs

-

-

-

-

-

-



 

Transactions with owners

-

-

7

-

(1,316)

(1,309)

 

 

 

At 31 December 2024

990

2,094

(98)

 

-

(2,041)

945

 

 

 


















 

Net profit for the financial period

-

-

-

-

(825)

(825)



Non-Controlling Interest

-

-

-

(293)

-

(293)



Foreign Exchange Gain

-

-

(1)

-

-

(1)



Total comprehensive income for the period

-

-

(1)

(293)

(825)

(1,119)

 

 

Non-Controlling Interest

-

-

-

7,108

-

7,108

 

 

Issue of share capital

1,087

7,131

-

-

-

8,218



Share issue costs

-

(287)

-

-

-

(287)



Transactions with owners

1,087

6,844

(1)

6,815

(825)

13,920

 

 

At 30 June 2025

2,077

8,938

(99)

 

6,815

(2,866)

14,865

 

 

 

 

 

 

 

 

 

Roebuck Food Group plc

 


 

 

Consolidated cash flow statement

 



For the six months ended 30 June 2025

 



 

Six months

Six months



Ended

ended



30 June

30 June



2025

2024



(Unaudited)

(Restated)



£'000

£'000


Loss on continuing operations before taxation

(1,115)

(325)


Foreign exchange loss/(gain)

-

-


Loss on discontinued activities

(3)

(3,753)


Finance expenses

5

7


Finance income

(3)

(3)


Impairment - Intangible Asset

271

30


Impairment - Goodwill

-

2,338


Depreciation - property, plant and equipment

37

33



(808)

(1,673)


Changes in working capital:

 



Increase in inventories

(75)

(145)


Increase in trade and other receivables

(269)

(246)


Increase in current assets held for sale

-

(4,274)


Increase in current liabilities held for sale

-

4,405


Decrease in payables

(653)

(37)


Taxation paid

-

-


Net cash used generated from operating activities

(1,805)

(1,970)


 

Investing activities

 



Payment for Investment

(833)

-


Proceeds from Sale of farming division

-

1,192


Payments to acquire subsidiary undertaking

(4,750)

-


Cash acquired as part of acquisition

2,542

-


Purchase of property, plant and equipment

(57)

(17)


Net cash (used in)/ generated from investing activities

(3,098)

1,175


 

Financing activities

 



Invoice finance repayments

(283)

(328)


Finance lease capital repayments

(12)

(12)


Net proceeds from issue of share capital

7,931

-


Net cash generated/(used) in financing activities

7,636

(340)


 

 



Net increase/(decrease) in cash and cash equivalents

2,733

(1,135)


 

Cash and cash equivalents, at beginning of period

115

1,186


Cash and cash equivalents end of period

2,848

51


 

Note : The accounting policies applied throughout the period are consistent with those applied for the year ended 31 December 2024, as set out in the 2024 Annual Report.

 

 

 

 

Enquiries:

Roebuck Food Group


Aidan Hughes, Finance Director

Telephone: + 44 28 3049 3399



 

Davy (Nomad)


Anthony Farrell

Telephone: + 353 1 679 6363

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR WPUMUBUPAGUU